Balance Promising Growth And Interest Rate Risk With These 30 Stocks
As the economic recovery continues, Goldman Sachs is advising investors to “balance the appeal of promising businesses with the risk that [interest] rates rise further…
As the economic recovery continues, Goldman Sachs is advising investors to “balance the appeal of promising businesses with the risk that [interest] rates rise further…
With a potential blockbuster drug in its pipeline that would also be the first new therapy for Alzheimer’s disease in decades, the stock featured in…
If stronger-than-expected fourth-quarter earnings, the prospect of massive government stimulus, and accelerating vaccine distribution has you feeling bullish, a perfect bet right now may be…
After crashing in March as the novel coronavirus became a global crisis dramatically affecting everyday life, small-cap stocks have staged a remarkable rebound. And while…
When it comes to the author of today’s article’s top biotech stock pick for 2021, an under-the-radar name, he explains that “Many of the reasons…
Investing in bitcoin has become a hot topic over the last few years, as has investing in the technology behind bitcoin and other cryptocurrencies: blockchain.…
In 2021, “The big stories…could come from vaccines that haven’t made it to market yet. It’s possible that the stocks of the companies developing these…
When it comes to stocks with the potential to make big moves in the first quarter of 2021, the author of today’s article advises that…
In a new research report, Stifel identifies its 2021 picks from the biotech sector – and today’s article highlights the five Buy-rated stocks from that…
“Many investors, especially more aggressive traders, look at lower-priced stocks as a way to not only make some good money but to get a higher…